BillionToOne Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 55
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $16M
Latest Deal Amount
  • Investors
  • 26

BillionToOne General Information

Description

Developer of a molecular counter platform designed to make molecular diagnostics more accurate, efficient, and accessible for all. The company's prenatal testing procedure focuses on quantitative biology and statistical learning methods to optimize signal-to-noise ratio, thereby making it possible to detect single-gene disorders, enabling expecting mothers to detect disorders such as sickle-cell disease, beta-thalassemia, spinal muscular atrophy, and cystic fibrosis through a simple blood test.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Devices and Supplies
Other Healthcare Services
Primary Office
  • 1455 Adams Drive
  • Suite 1110
  • Menlo Park, CA 94025
  • United States
+1 (650) 000-0000

BillionToOne Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BillionToOne Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series A) 25-Feb-2020 $16M 000.00 00000 Completed Generating Revenue
4. Early Stage VC (Series A) 13-Mar-2019 0000 000.00 0000 Completed Clinical Trials - General
3. Grant 01-Jan-2018 00000 00.00 Completed Clinical Trials - General
2. Seed Round 30-Sep-2017 $2.5M $2.5M Completed Clinical Trials - General
1. Accelerator/Incubator 22-Aug-2017 Completed Pre-Clinical Trials
To view BillionToOne’s complete valuation and funding history, request access »

BillionToOne Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-6 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A-5 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-4 00,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-3 000,000 00.000000 00 00 00 00 0.000
Series A-2 1,137,210 $0.000010 $0.8 $0.8 1x $0.8 5.83%
Series A-1 1,349,650 $0.000010 $0.4 $0.4 1x $0.4 6.92%
To view BillionToOne’s complete cap table history, request access »

BillionToOne Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a molecular counter platform designed to make molecular diagnostics more accurate, efficient, and accessibl
Laboratory Services (Healthcare)
Menlo Park, CA
55 As of 2020
000.00
0000 0000-00-00
00000000000 000.00

0000000

tion ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
000000000000000000 00000000
San Francisco, CA
0000 As of 0000
00000
000000000 00000

00000000

ate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proiden
0000000000 000000000
Cambridge, MA
0000 As of 0000
00000
00 0000-00-00
00000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BillionToOne Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Invitae Formerly VC-backed San Francisco, CA 0000 00000 000000000 00000
0000000000 0000000 Corporate Backed or Acquired Cambridge, MA 0000 00000 00000000000
000000 00000000 Corporation Salt Lake City, UT 0000 00000 000000 - 000 00000
000000 Formerly VC-backed San Carlos, CA 0000 00000 000000 - 000 00000
00000000 000000 Formerly VC-backed Redwood City, CA 000 00000 00000000 00000
You’re viewing 5 of 7 competitors. Get the full list »

BillionToOne Executive Team (3)

Name Title Board Seat Contact Info
Oguzhan Atay Ph.D Co-Founder, Chief Executive Officer & Chairman
David Tsao Ph.D Co-Founder, Chief Technology Officer & Board Member
To view BillionToOne’s complete executive team members history, request access »

BillionToOne Board Members (5)

Name Representing Role Since
David Tsao Ph.D BillionToOne Co-Founder, Chief Technology Officer & Board Member 000 0000
Firat Ileri Hummingbird Ventures Board Member 000 0000
Oguzhan Atay Ph.D BillionToOne Co-Founder, Chief Executive Officer & Chairman 000 0000
Swaroop Kolluri Neotribe Ventures Board Member 000 0000
To view BillionToOne’s complete board members history, request access »

BillionToOne Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BillionToOne Investors (26)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Libertus Capital Venture Capital Minority 000 0000 000000 0
Enis Hulli Angel (individual) Minority 000 0000 000000 0
Henry Senger Angel (individual) Minority 000 0000 000000 0
HOF Capital Venture Capital Minority 000 0000 000000 0
Hummingbird Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 26 investors. Get the full list »